Evolving multidimensional pharmacological approaches to CNV therapy in AMD

Volume: 43, Issue: 2, Pages: 147 - 154
Published: Nov 7, 2017
Abstract
Purpose: The leading cause of severe visual loss world-wide is age-related macular degeneration. Although anti-Vascular Endothelial Growth Factor agents have significantly led to the initial pharmacologic reversal of vision loss in many cases of exudative macular degeneration, there still has been recurrence of choroidal neovascularization, and/or the onset of chorioretinal atrophy with fibrosis.Materials and Methods: In this review we discuss...
Paper Details
Title
Evolving multidimensional pharmacological approaches to CNV therapy in AMD
Published Date
Nov 7, 2017
Volume
43
Issue
2
Pages
147 - 154
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.